Barcelona will once again host BIO-Europe Spring, the European partnering congress that specializes in biotechnology and the pharmaceutical industry, which will take place in the city from March 22 to 24, 2021.
BIO-Europe Spring (BES) is organized by EBD Group, which has chosen Barcelona again to host the fair after beating participation records in the previous editions held in the Catalan capital, in 2010, 2013 and 2017.
“BIO-Europe Spring is the most significant annual springtime industry event where top executives from global biotech, pharma and finance access hundreds of potential partners to make their companies’ collaborative goals a reality,” said Pam Putz, Managing Director Europe for EBD Group. “After delivering the event in a fully digital format this week, we’re looking forward to gathering in person in 2021 in beautiful Barcelona, where we’ve had three highly productive and successful BIO-Europe Spring conferences in the last ten years.”
The latest edition hosted in Barcelona, in 2017, welcomed more than 2,500 healthcare and life sciences professionals from a total of 1,450 companies in 58 countries. More than 195 delegates from 110 companies and organizations in the BioRegion took part, including Biocat, with a booth that acted as a meeting point for the whole Catalan delegation.
“Hosting BIO-Europe Spring again confirms Barcelona’s role as one of Europe’s main innovation hubs,” highlights Biocat CEO Jordi Naval. “The international visibility this type of conferences bring helps attract venture capital and top executives looking for start-ups and commercial deals, opening up many opportunities for companies in the BioRegion of Catalonia.”
Barcelona is taking the baton from Paris, which was hosting the fair this year although in the end it had to be held digitally due to Covid-19. Some fifteen companies from the BioRegion of Catalonia participated in this digital fair, including Ability Pharmaceuticals, Almirall, Esteve, Gebro Pharma, GP Pharm, IRB Barcelona, KYMOS Pharma Services, Laboratorios Rubió, Laboratorios Salvat, Neuraxpharm Holdco Spain, PANGAEA ONCOLOGY, Pharmacelera, Trifermed and usMIMA. Biocat also had an online presence at the fair and helped raise awareness of the Catalan presence internationally.
The 2020 program included company presentations, pre-recorded panels, an exhibition and teleconferences, all online. The last edition of 2019, held last spring in Vienna, brought together nearly 2,500 delegates from over 1,400 companies in 55 countries, hosted 15,400 meetings and saw 3,600 licensing deals closed.
AtCDF3 gene induced greater production of sugars a...
Un estudio con datos de los últimos 35 años, ind...
Un equipo de investigadores de la Universidad Juli...
En nuestro post hablamos sobre este interesante tipo de célula del...
Theriva™ Biologics has announced the presentation of preclinical da...
